ATE332701T1 - Verfahren zur herstellung von nordamerikanischen ginseng fraktionen, enthaltende produkte, und verwendung als immunmodulatoren - Google Patents

Verfahren zur herstellung von nordamerikanischen ginseng fraktionen, enthaltende produkte, und verwendung als immunmodulatoren

Info

Publication number
ATE332701T1
ATE332701T1 AT98963784T AT98963784T ATE332701T1 AT E332701 T1 ATE332701 T1 AT E332701T1 AT 98963784 T AT98963784 T AT 98963784T AT 98963784 T AT98963784 T AT 98963784T AT E332701 T1 ATE332701 T1 AT E332701T1
Authority
AT
Austria
Prior art keywords
north american
american ginseng
products containing
fractions
immune modulators
Prior art date
Application number
AT98963784T
Other languages
English (en)
Inventor
Jacqueline J Shan
Peter K T Pang
Buhan Huang
Lei Ling
Original Assignee
C V Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by C V Technologies Inc filed Critical C V Technologies Inc
Application granted granted Critical
Publication of ATE332701T1 publication Critical patent/ATE332701T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55583—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588—Adjuvants of undefined constitution

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • AIDS & HIV (AREA)
  • Transplantation (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Compounds Of Unknown Constitution (AREA)
AT98963784T 1997-12-12 1998-12-11 Verfahren zur herstellung von nordamerikanischen ginseng fraktionen, enthaltende produkte, und verwendung als immunmodulatoren ATE332701T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US6953497P 1997-12-12 1997-12-12

Publications (1)

Publication Number Publication Date
ATE332701T1 true ATE332701T1 (de) 2006-08-15

Family

ID=22089640

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98963784T ATE332701T1 (de) 1997-12-12 1998-12-11 Verfahren zur herstellung von nordamerikanischen ginseng fraktionen, enthaltende produkte, und verwendung als immunmodulatoren

Country Status (12)

Country Link
US (7) US6432454B1 (de)
EP (1) EP1037645B1 (de)
JP (2) JP4458505B2 (de)
KR (2) KR100855409B1 (de)
CN (1) CN1285752B (de)
AT (1) ATE332701T1 (de)
AU (1) AU752702B2 (de)
CA (1) CA2314453C (de)
DE (1) DE69835230T2 (de)
DK (1) DK1037645T3 (de)
NZ (1) NZ504975A (de)
WO (1) WO1999030725A1 (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6432454B1 (en) * 1997-12-12 2002-08-13 C. V. Technologies, Inc. Processes of making north american ginseng fractions, products containing them, and use as immunomodulators
AU3478600A (en) * 1999-02-25 2000-09-14 Cv Technologies Inc. Treatment of autoimmune diseases with american ginseng extract
TWI222357B (en) * 2000-01-11 2004-10-21 Medical & Pharm Ind Tech & Dev Anti-ulcer pharmaceutical composition and the preparation and use thereof
GB2364640B (en) * 2000-07-11 2002-12-04 Pharmaceutical Ind Tech & Dev Anti-ulcer pharmaceutical composition and the preparation thereof
ES2193874B1 (es) * 2002-04-03 2005-03-01 Puleva Biotech, S.A. Compuestos naturales y derivados de estos para la prevencion y el tratamiento de enfermedades cardiovasculares, hepaticas, renales y cosmeticas.
KR100594353B1 (ko) * 2002-05-28 2006-07-03 주식회사 엠디바이오알파 신규한 인삼잎 및 줄기 다당체, 그 제조방법 및 그를활성성분으로 함유하는 항암제 및 항암보조제 조성물
WO2004037165A2 (en) * 2002-08-23 2004-05-06 The Research Foundation Of State University Of New York Nitric oxide and its biomedical significance
AR046078A1 (es) 2003-08-06 2005-11-23 Senomyx Inc Nuevos sabores, modificadores de sabores, sustancias gustativas, mejoradores de gusto, sustancias gustativas y/o mejoradoras del gusto umani o dulce y uso de los mismos.
US20050079234A1 (en) * 2003-08-27 2005-04-14 Chiang Yang Chi Compositions comprising herbs and method for immunomodulation
KR101102480B1 (ko) * 2004-04-27 2012-01-05 노부유키 하야시 가압 열매체를 이용한 추출방법 및 그 장치
KR100456089B1 (ko) * 2004-07-15 2004-11-09 박용진 항암 활성을 갖는 산삼 추출정제액을 정제하는 방법 및이를 함유하는 조성물
CN100509006C (zh) 2005-03-25 2009-07-08 北京欧纳尔生物工程技术有限公司 治疗抑郁症的药物组合物及其制法
DE602006017423D1 (de) * 2005-11-14 2010-11-18 Unilever Nv Essbares produkt, das ginseng-polysaccharide und gesunde bakterien enthält
US20120263806A1 (en) * 2007-05-16 2012-10-18 Miller Sandra Uses of North American Ginseng Fractions for Treating Leukemia
WO2008139241A1 (en) * 2007-05-16 2008-11-20 C.V. Technologies, Inc. Uses of north american ginseng fractions for treating leukemia
US20090047405A1 (en) * 2007-08-16 2009-02-19 Conopco, Inc., D/B/A Unilever Food composition with therapeutic agents
KR101018989B1 (ko) 2007-10-31 2011-03-07 내추럴초이스 (주) 홍삼박을 이용한 홍삼 다당체의 생산방법
WO2009071425A1 (en) * 2007-12-07 2009-06-11 Unilever Nv Edible product having an immunostimulating effect
MY158195A (en) * 2008-02-29 2016-09-15 Afexa Life Sciences Inc Activation of innate and adaptive immune responses by a ginseng extract
BRPI0919298A2 (pt) * 2008-09-30 2019-09-24 Unhwa Corp composição para a prevenção ou o tratamento da aids que compreende a linhagem de células do tronco da planta derivada do câmbio da panax ginseng incluindo ginseng selvagem ou ginseng como ingrediente ativo.
KR101067959B1 (ko) * 2008-10-29 2011-09-26 구성학 감기 및 독감의 치료와 예방에 효과적인 발효유지 조성물의제조방법
WO2010095911A2 (ko) * 2009-02-23 2010-08-26 주식회사 운화 산삼 또는 인삼을 포함한 인삼류의 형성층 유래 식물줄기세포주를 유효성분으로 함유하는 면역증강용 조성물
US8574639B2 (en) 2010-08-17 2013-11-05 ILHWA Co., Ltd. Fermented ginseng concentrate having IH-901
WO2012148277A1 (en) 2011-04-29 2012-11-01 Unilever N.V. Method for isolation of polysaccharides
US20140255526A1 (en) * 2011-10-28 2014-09-11 Afexa Life Sciences Inc. Use of a ginseng extract to prevent and treat alopecia areata
CN103656113A (zh) * 2012-09-13 2014-03-26 江中药业股份有限公司 一种调节免疫的中药组合物及其制备方法
CN102928373B (zh) * 2012-11-26 2015-05-13 广东省农业科学院花卉研究所 一种石斛多糖含量的测定方法及其应用
KR102200012B1 (ko) * 2013-04-02 2021-01-08 (주)아모레퍼시픽 인삼열매 추출물을 포함하는 뇌 활성화 조성물
WO2014196817A1 (ko) * 2013-06-04 2014-12-11 중앙대학교 산학협력단 자일리톨을 유효성분으로 함유하는 인플루엔자 바이러스 감염증 예방 또는 치료용 조성물
US20150044306A1 (en) 2013-08-12 2015-02-12 Melvin Mitchell Process for fractionation and extraction of herbal plant material to isolate extractives for pharmaceuticals and nutraceuticals
KR102184157B1 (ko) * 2019-01-08 2020-11-30 주식회사 바이오에프디엔씨 항상성 증가를 통한 피부면역개선, 외부환경에 대한 피부보호 및 피부활력증진을 위한 인삼 유래 테트라펩타이드를 함유하는 화장료 조성물
WO2022126261A1 (en) * 2020-12-15 2022-06-23 Shan Jacqueline J American ginseng root fractions, processes of their preparation and uses thereof
CN114848695A (zh) * 2022-03-25 2022-08-05 潍坊医学院 一种人参稀有皂苷与西洋参多糖的组合物及其应用
CN117050207A (zh) * 2023-09-11 2023-11-14 湖南省中医药研究院 一种西洋参多糖、提取方法与其调节机体抗流感免疫的应用
GB202316295D0 (en) 2023-10-24 2023-12-06 Amazentis Sa Composition
GB202411739D0 (en) 2024-08-08 2024-09-25 Amazentis Sa Compositions

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4912020A (de) * 1972-05-17 1974-02-02
DE3070086D1 (en) * 1979-12-03 1985-03-14 Kitasato Inst A process for preparing substances having interferon inducing activity
JPS6118722A (ja) * 1984-07-05 1986-01-27 Wakunaga Seiyaku Kk 生体防御能亢進剤
JPS61109732A (ja) * 1984-10-31 1986-05-28 Wakunaga Seiyaku Kk 殺腫瘍性物質誘発剤
US4708949A (en) * 1985-09-24 1987-11-24 Yaguang Liu Therapeutic composition from plant extracts
US4706949A (en) * 1985-12-17 1987-11-17 Dossey Robert L Vise jaw support system and interchangeable vise jaws therefor
SU1410322A1 (ru) * 1986-03-07 1996-03-27 Владивостокский государственный медицинский институт Способ получения тритерпеновых гликозидов-панаксозидов из корней женьшеня (panax ginseng c.a.mey)
JPH0643327B2 (ja) * 1987-03-27 1994-06-08 株式会社ツムラ 免疫賦活剤
US5071839A (en) * 1987-11-02 1991-12-10 Yaguang Liu Safe pharmaceutical composition for decreasing side effects of antiviral drugs and increasing the immune function (SDI) II
JPH0245499A (ja) * 1988-08-06 1990-02-15 Wakunaga Pharmaceut Co Ltd オタネニンジン糖タンパク質およびその用途
JPH0245501A (ja) * 1988-08-06 1990-02-15 Wakunaga Pharmaceut Co Ltd 竹節ニンジン多糖およびその用途
JPH05317041A (ja) * 1991-06-05 1993-12-03 Nippon Oil Co Ltd 動物細胞増殖促進剤及び無血清培地
JPH0639759A (ja) * 1992-04-20 1994-02-15 Tokico Ltd 工業用ロボット装置
JPH069418A (ja) * 1992-06-29 1994-01-18 Nitto Denko Corp パナキンケコール化合物、及び制癌剤
CN1088448A (zh) * 1992-12-25 1994-06-29 彭德赐 西洋参多糖营养液和西洋参多糖胶囊及其制备方法
JPH0782167A (ja) * 1993-06-29 1995-03-28 Japan Energy Corp 血清ｃｓｆ活性誘導剤及びその製造方法
US5840309A (en) * 1994-10-03 1998-11-24 La Prairie Sa Stimulating fibroblasts and/or keratinocytes
KR100192678B1 (ko) * 1995-06-07 1999-06-15 손경식 약효가 증강된 가공인삼 제품
US6083932A (en) * 1997-04-18 2000-07-04 Cv Technologies Inc. Pharmaceutical compositions derived from ginseng and methods of treatment using same
KR20010023208A (ko) * 1997-08-28 2001-03-26 브루스, 제임스 에이취 허브 추출물의 화학 및 약리학적 표준화
US6432454B1 (en) * 1997-12-12 2002-08-13 C. V. Technologies, Inc. Processes of making north american ginseng fractions, products containing them, and use as immunomodulators
AU3478600A (en) 1999-02-25 2000-09-14 Cv Technologies Inc. Treatment of autoimmune diseases with american ginseng extract
DE60015734D1 (de) * 1999-02-26 2004-12-16 Inspire Pharmaceuticals Durham Verwendung von dinukleotidtriphosphaten, cytidindiphosphaten und adenindiphosphaten zur herstellung einer pharmazeutischen zubereitung zur förderung der schleimauthydratation
US6555527B1 (en) * 1999-08-27 2003-04-29 Korea Atomic Energy Research Institute Hematopoietic, myeloprotecting, antitumor immune cells generating and radiosensitizing polysaccharide isolated from Panax ginseng

Also Published As

Publication number Publication date
US7067160B2 (en) 2006-06-27
HK1032358A1 (en) 2001-07-20
US20080286389A1 (en) 2008-11-20
US20030124207A1 (en) 2003-07-03
DK1037645T3 (da) 2006-11-06
DE69835230T2 (de) 2007-07-05
KR100855409B1 (ko) 2008-08-29
EP1037645A4 (de) 2004-03-03
EP1037645B1 (de) 2006-07-12
JP2009256387A (ja) 2009-11-05
DE69835230D1 (de) 2006-08-24
AU752702B2 (en) 2002-09-26
CN1285752B (zh) 2011-05-25
CN1285752A (zh) 2001-02-28
US20100278945A1 (en) 2010-11-04
US20050196471A1 (en) 2005-09-08
CA2314453C (en) 2009-03-03
JP2002508329A (ja) 2002-03-19
US7186423B2 (en) 2007-03-06
US20030077341A1 (en) 2003-04-24
US6432454B1 (en) 2002-08-13
NZ504975A (en) 2004-02-27
AU1903499A (en) 1999-07-05
EP1037645A1 (de) 2000-09-27
CA2314453A1 (en) 1999-06-24
KR20010032984A (ko) 2001-04-25
KR20070093155A (ko) 2007-09-17
US7413756B2 (en) 2008-08-19
US7763290B2 (en) 2010-07-27
WO1999030725A1 (en) 1999-06-24
KR100780521B1 (ko) 2007-11-29
JP4458505B2 (ja) 2010-04-28
US20040137087A1 (en) 2004-07-15

Similar Documents

Publication Publication Date Title
ATE332701T1 (de) Verfahren zur herstellung von nordamerikanischen ginseng fraktionen, enthaltende produkte, und verwendung als immunmodulatoren
ATE261337T1 (de) Verfahren zur herstellung von morphologisch einheitlichen mikro- und nanopartikeln mittels eines mikromischers
NZ543467A (en) The severe acute respiratory syndrome coronavirus
WO2004001007A3 (en) Buffered formulations for concentrating antibodies and methods of use thereof
EP1064308A4 (de) Verfahren zur identifizierung von induktoren und inhibitoren proteolytischer antikörper, zusammensetzungen sowie deren verwendungen
ATE296315T1 (de) Galactosylierte glykoproteine enthaltende zusammensetzungen und verfahren zur deren herstellung
EP1077719A4 (de) Verabreichungssystem für impfstoffe
ATE373078T1 (de) Gleichzeitige stimulation und konzentration von zellen
ATE226960T1 (de) Verfahren zur herstellung von cardiodilatin- fragmenten, hochgereinigte cardiodilatin- fragmente und zwischenprodukte zu deren herstellung
DE69325393D1 (de) Pharmazeutische zusammensetzungen und verfahren unter verwendung von isobutyramid zur behandlung von betaglobinerkrankungen
ATE278390T1 (de) Verfahren zur herstellung von arzneistoffpartikeln
ATE394490T1 (de) Mutante bakteriestämme vom genus sphingonomas die defizient in der herstellung von polyhydroxybutyrate sind, und verfahren zur klärung von sphinganen
IL165988A0 (en) Process for the preparation of fibrinogen
DE10193689D2 (de) Retardpartikeldispersion
ES2177316T3 (es) Anticuerpos humanos antifacotores ix/ixa.
ATE409178T1 (de) Verfahren zur produktion von iohexol hoher reinheit
ATE151078T1 (de) Verfahren und zwischenprodukte synthetischer antikörperderivate
ATE404674T1 (de) Verfahren zur herstellung von ergosterol und dessen zwischenprodukten mittels rekombinanter hefen
ATE442361T1 (de) Verfahren zur herstellung kristalliner formen von orlistat
DE69535267D1 (de) Verwendung zur verabreichung von östrogen
ATE271871T1 (de) Substanzen zur therapie von erkrankungen, die durch hochproliferierende zellen verursacht werden
ATE174756T1 (de) Zyklische anti-tumorpromotor-verbindungen, zusammensetzungen und verfahren zur herstellung sowie ihre verwendung
EP1320351A4 (de) Methoden der zubereitung von immunglobulin und dessen verwendungen
BRPI0408077A (pt) composições e métodos para prevenção e tratamento de doenças relacionadas com endotoxina e condições
DE50214894D1 (de) Verfahren zur herstellung von oxirancarbonsäuren und derivaten davon

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1037645

Country of ref document: EP

EEIH Change in the person of patent owner